SBIR/STTR Research Award
Selenium Enriched Plant Material for Chemoprevention
Award amount
$213,069Program and phase
STTR · Phase IIAward year
2001Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- NuCycle Therapy, Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (Scanned from the Applicant's Abstract): Selenium may play a
significant role in cancer prevention. Dietary selenium aids in preventing
several types of carcinomas including lung, prostate, and colon. The potency of
Se varies with its chemical form. The most effective compounds are rapidly and
quantitatively transformed by the body, such as Se-methylselenocysteine, one of
the most effective anti-carcinogenic Se-compounds. An inexpensive way to
provide dietary Se would be to enrich certain foodstuffs with Se, preferably in
the form of Se-methylselenocysteine. We propose to create this type of product
by engineering crop plants to accumulate Se -methylselenocysteine. Phase I
studies have established the feasibility of altering selenium metabolism in
Arabidopsis thaliana by overexpressing ATP sulfurylase, resulting in more
efficient assimilation of selenate. Selenocysteine methyltransferase from A.
bisulcatus was also expressed in A. thaliana. Further improvements in the
ability of these plants to take up and transform selenate involve cloning
additional genes involved in Se accumulation. Based on results of the Phase I
research, genes involved in Se uptake in the roots and chemical reduction of
selenate to selenite in the tissues will be targeted. We will transfer these
genes into Brassica juncea, the Indian mustard plants, to produce a
commercially viable high Se-methylselenocysteine plant product.
PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE
Technology keywords
Not reported